A new extended release synthetic narcotic opioid analgesic is due to be available on the market in March. Zohydro is an extended release of the highly abused hydrocodone with a dose as high as 50 mg. The FDA feels that benefits of the product outweigh the risk and limiting access to treatments is not a good overall solution. According to the manufacturer’s spokeswoman, the company Zogenix is evaluating two different technologies to ensure developing the most effective formulation that minimize misuse and abuse. What are your thoughts on this controversy?

For additional information please see WebMdImage courtesy of [David Castillo Dominici]/freedigitalphotos.net